Compounds > n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine
Page last updated: 2024-11-05

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Heart Disease, Ischemic

n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Heart Disease, Ischemic in 1 studies

N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shmist, YA1
Kamburg, R1
Ophir, G1
Kozak, A1
Shneyvays, V1
Appelbaum, YJ1
Shainberg, A1

Other Studies

1 other study available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Heart Disease, Ischemic

ArticleYear
N,N,N',N'-tetrakis(2-pyridylmethyl)-ethylenediamine improves myocardial protection against ischemia by modulation of intracellular Ca2+ homeostasis.
    The Journal of pharmacology and experimental therapeutics, 2005, Volume: 313, Issue:3

    Topics: Animals; Anti-Arrhythmia Agents; Calcium; Cell Hypoxia; Chelating Agents; Ethylenediamines; Homeosta

2005